252 related articles for article (PubMed ID: 25139296)
21. Efficacy of computed virtual chromoendoscopy on colorectal cancer screening: a prospective, randomized, back-to-back trial of Fuji Intelligent Color Enhancement versus conventional colonoscopy to compare adenoma miss rates.
Chung SJ; Kim D; Song JH; Park MJ; Kim YS; Kim JS; Jung HC; Song IS
Gastrointest Endosc; 2010 Jul; 72(1):136-42. PubMed ID: 20493487
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.
Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM
J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988
[TBL] [Abstract][Full Text] [Related]
23. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
[TBL] [Abstract][Full Text] [Related]
24. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
Wang Q; Zhang H; Shen X; Ju S
Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
[TBL] [Abstract][Full Text] [Related]
25. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
[TBL] [Abstract][Full Text] [Related]
26. Methylation changes in faecal DNA: a marker for colorectal cancer screening?
Müller HM; Oberwalder M; Fiegl H; Morandell M; Goebel G; Zitt M; Mühlthaler M; Ofner D; Margreiter R; Widschwendter M
Lancet; 2004 Apr; 363(9417):1283-5. PubMed ID: 15094274
[TBL] [Abstract][Full Text] [Related]
27. Screening colonoscopy in first-degree relatives of patients with colorectal cancer.
Barzin G; Ostovaneh MR; Tayebi S; Vahedi H; Ansari R
Arch Iran Med; 2014 Feb; 17(2):115-7. PubMed ID: 24527972
[TBL] [Abstract][Full Text] [Related]
28. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals.
Álvarez C; Andreu M; Castells A; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas Á; Carballo F; Morillas JD; Hernández C; Jover R; Sarasqueta C; Enriquéz-Navascués JM; Hernández V; Estévez P; Macenlle R; Sala T; Balaguer F; Pellisé M; Moreira L; Gil I; Peris A; González-Rubio F; Ferrández A; Poves C; Ponce M; Grau J; Serradesanferm A; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; Santander C; Díaz Tasende J; Herreros A; Cacho G; Barranco LE; Bessa X;
Gastrointest Endosc; 2013 Aug; 78(2):333-341.e1. PubMed ID: 23623039
[TBL] [Abstract][Full Text] [Related]
29. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.
Chen WD; Han ZJ; Skoletsky J; Olson J; Sah J; Myeroff L; Platzer P; Lu S; Dawson D; Willis J; Pretlow TP; Lutterbaugh J; Kasturi L; Willson JK; Rao JS; Shuber A; Markowitz SD
J Natl Cancer Inst; 2005 Aug; 97(15):1124-32. PubMed ID: 16077070
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition.
Huang YC; Lee CT; Lee JC; Liu YW; Chen YJ; Tseng JT; Kang JW; Sheu BS; Lin BW; Hung LY
Oncotarget; 2016 Nov; 7(47):76852-76866. PubMed ID: 27764771
[TBL] [Abstract][Full Text] [Related]
31. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.
Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q
Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of different stool tests for the detection of cancer of the colon].
Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
[TBL] [Abstract][Full Text] [Related]
34. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
[TBL] [Abstract][Full Text] [Related]
35. miR-194 as a predictor for adenoma recurrence in patients with advanced colorectal adenoma after polypectomy.
Wang ZH; Ren LL; Zheng P; Zheng HM; Yu YN; Wang JL; Lin YW; Chen YX; Ge ZZ; Chen XY; Hong J; Fang JY
Cancer Prev Res (Phila); 2014 Jun; 7(6):607-16. PubMed ID: 24691499
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of autofluorescence colonoscopy for the detection and diagnosis of colonic polyps.
McCallum AL; Jenkins JT; Gillen D; Molloy RG
Gastrointest Endosc; 2008 Aug; 68(2):283-90. PubMed ID: 18329642
[TBL] [Abstract][Full Text] [Related]
37. Micronucleus frequency in human peripheral blood lymphocytes as a biomarker for the early detection of colorectal cancer risk.
Maffei F; Zolezzi Moraga JM; Angelini S; Zenesini C; Musti M; Festi D; Cantelli-Forti G; Hrelia P
Mutagenesis; 2014 May; 29(3):221-5. PubMed ID: 24668056
[TBL] [Abstract][Full Text] [Related]
38. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.
Oh T; Kim N; Moon Y; Kim MS; Hoehn BD; Park CH; Kim TS; Kim NK; Chung HC; An S
J Mol Diagn; 2013 Jul; 15(4):498-507. PubMed ID: 23747112
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
